Patent · US Active

Identification of genetic variants

US9447469B2 · kind B2 · utility

3Cited by
1References
21Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJul 3, 2014
Grant dateSep 20, 2016
Priority date—
Expiry dateJul 3, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/156
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides a method for identifying whether a subject is more or less likely to be responsive to VEGF-based therapy, comprising screening a nucleic acid sample obtained from the subject to provide output information which identifies the presence or absence of an allelic variant, wherein the presence or absence of an allelic variant indicates whether the subject is more or less likely to be responsive to VEGF-based therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.